£1.1M
The round was led by Deepbridge Capital to help manufacture trial units for a new urinary tract infection diagnostic device.
F
FluoretiQ
FluoretiQ develops rapid diagnostic technology to detect bacterial infections within minutes.
Bristol, UK—Founded 2017
£1.1MTotal raised
University of Bristol spin-out developing rapid diagnostic platforms to identify bacterial infections and support appropriate antibiotic prescriptions.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Cash, assets and headcount from FluoretiQ's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Team
ND
Neciah Dorh
CEO